SHINE to Build Facility in Europe
SHINE Medical Technologies will build its European medical isotope production facility in the Netherlands, the company announced today. According to a release, the European facility, which will be located in…
SHINE Medical Technologies will build its European medical isotope production facility in the Netherlands, the company announced today. According to a release, the European facility, which will be located in…
NorthStar Medical Radioisotopes has received two custom-built IBA Rhodotron TT 300-HE electron beam accelerators at its facility, the company announced recently. According to a release, the accelerators are critical components…
OnLume Surgical announced recently that it has closed a $7 million Series A financing round. “The completion of the Series A financing, plus the Phase II grant from NCI, provides the…
HealthMyne’s technology as a radiomics tool to inform clinical decision-making, identify imaging biomarkers and predict tumor response to cancer treatment was validated by Cancer Control, the company announced recently. “By extracting…
SHINE Medical Technologies and Phoenix have completed a merger under which Phoenix has become a wholly owned subsidiary of SHINE, the companies announced today. “SHINE and Phoenix have shared a…
Promega has opened the Kornberg Center, its newly constructed research and development facility, the company announced today. According to a release, the three-story, 280,000-square-foot building will support core product and technology…
Stem Pharm has been awarded a $1.7 million SBIR grant from the National Institute of Environmental Health Sciences of the National Institutes of Health (NIH), the company announced recently. According…
SHINE Medical Technologies has completed exterior construction of its medical isotope production facility and made it weathertight for protection, the company announced today. According to a release, the facility can withstand…
BioForward and BIOQuebec, Quebec’s largest biosciences network, will sign a memorandum of understanding to form a cooperative relationship, the organizations announced recently. “This step will take us both a long…
HealthMyne’s radiomic and quantitative imaging solution was used in a lung carcinoma study that was published in Cancer Control, the company announced recently. According to a release, the study demonstrated HealthMyne’s…